NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. 

Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes.

NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world.   From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets.

In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies.

NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challenge”, “Speed”, and “Investigation”. 


Pharmaceutical

Life Sciences

NS Pharma, Inc.

Yoshihiko Makita

Manabu Beppu

Koji Kimura

Tatsuaki Morokata

Takeshi Seita

Leslie Magnus

Gardner Gendron

The Leadership Team at NS Pharma, Inc. plays a critical role in guiding the strategic direction of the company, fostering partnerships with global pharmaceutical entities, and overseeing the development and commercialization of drug candidates. This team collaborates closely with the parent company, Nippon Shinyaku Co., Ltd., to ensure the effective execution of clinical studies while promoting innovation in pharmaceutical development. Through a commitment to the principles of "Challenge," "Speed," and "Investigation," the Leadership Team drives NSP's mission to enhance healthcare solutions across Japan and Asia.

Leadership Team

Patient Access and Market Engagement

Clinical Research and Regulatory Affairs

��

Leadership Team

About

Team members

Other teams at NS Pharma, Inc.

Patient Access and Market Engagement

Clinical Research and Regulatory Affairs

��������

Leadership Team

About

Team members

Other teams at NS Pharma, Inc.

Patient Access and Market Engagement

Clinical Research and Regulatory Affairs

��